[D2-A1] Advancing drug development: Comprehensive and optimum approaches to the immunogenicity assessment

9:40 AM - 10:10 AM JST(12:40 AM - 1:10 AM UTC)

[D2-A1-02] Draft Guideline for Immunogenicity Assessment of Biopharmaceuticals

*Akiko Ishii-Watabe¹ (1. National Institute of Health Sciences)

Password required to view

Log in

or